Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

BillionerOfKing Feb. 3 at 8:30 PM

$LITS Current Stock Price: $1.12 Contracts to trade: $2.5 LITS Feb 20 2026 Call Entry: $0.05 Exit: $0.09 ROI: 89% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Johnnyanynomous Feb. 3 at 8:20 PM

$LITS $PSQH $QQQ $SPY $TSLA you know it’s not good when even the paid Russian bot pumper trolls are posting random screen shots of random shit just to try and keep it alive. Seriously look at any of her screenshots they don’t relate to this stock at all lol.

1 · Reply

Bestbee Feb. 3 at 6:57 PM

$LITS Straight to 1,00$

0 · Reply

Svitlana Feb. 3 at 3:23 PM

$LITS $QQQ $SPY $TSLA $PSQH 🦆

0 · Reply

Statistical Feb. 3 at 2:56 PM

$LTC.X there are quite literally algorithms and bad actors that probably want all of the DATS to go to 0. $LITS is going to 0, any other DAYS associated with crypto are going to 0. Only then will the market go up.

0 · Reply

R3JS Feb. 2 at 3:02 PM

$LTC.X Not enough inflows for our stock market plays $LITS $LTCC $LTCN yet. They also are being manipulated they should be down further to catch up to our weekend drop. Then money would flow like a river! Almost like whales don’t want money to flow in. Today at market close should be the tell. Watch all three close.

1 · Reply

onemillion2012 Feb. 2 at 5:25 AM

$LITS looks like a dollar today..😭

0 · Reply

End00Game Jan. 31 at 1:07 AM

$LITS I wouldn't be a buyer here. no revs $MSTR

0 · Reply

gerbens Jan. 30 at 12:56 AM

$LTC.X $LITS earnings in 2 weeks. Wonder how much they bought down here...

0 · Reply

BlueQuant Jan. 29 at 7:42 PM

$LTC.X $LITS What does the market systematically misprice when narratives dominate? Historically, it’s been boring, durable, scarce assets that never die.

0 · Reply

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 5, 2025, 8:00 AM EDT - 6 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 6 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 7 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 1:22 PM EDT - 7 months ago

Why Is MEI Pharma Stock Soaring On Friday?

Jul 18, 2025, 8:30 AM EDT - 7 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 9 months ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

May 14, 2024, 10:38 AM EDT - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

May 9, 2024, 4:02 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Apr 11, 2024, 8:02 AM EDT - 1 year ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 26, 2023, 7:47 PM EDT - 2 years ago

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 2 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 13, 2023, 4:05 PM EDT - 2 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 2 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 2 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 2 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 1, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

May 30, 2023, 5:40 PM EDT - 2 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

BillionerOfKing Feb. 3 at 8:30 PM

0 · Reply

Johnnyanynomous Feb. 3 at 8:20 PM

1 · Reply

Bestbee Feb. 3 at 6:57 PM

$LITS Straight to 1,00$

0 · Reply

Svitlana Feb. 3 at 3:23 PM

$LITS $QQQ $SPY $TSLA $PSQH 🦆

0 · Reply

Statistical Feb. 3 at 2:56 PM

0 · Reply

R3JS Feb. 2 at 3:02 PM

1 · Reply

onemillion2012 Feb. 2 at 5:25 AM

$LITS looks like a dollar today..😭

0 · Reply

End00Game Jan. 31 at 1:07 AM

$LITS I wouldn't be a buyer here. no revs $MSTR

0 · Reply

gerbens Jan. 30 at 12:56 AM

$LTC.X $LITS earnings in 2 weeks. Wonder how much they bought down here...

0 · Reply

BlueQuant Jan. 29 at 7:42 PM

$LTC.X $LITS What does the market systematically misprice when narratives dominate? Historically, it’s been boring, durable, scarce assets that never die.

0 · Reply

Bestbee Jan. 29 at 7:41 PM

$LITS

0 · Reply

BlueQuant Jan. 29 at 7:39 PM

$LTC.X $LITS “Survivorship is underrated alpha.”

0 · Reply

onemillion2012 Jan. 29 at 6:36 PM

$LITS how many Germens invested here.. like if you are Germen. And did you invest because Alexander S. Is invested

0 · Reply

R3JS Jan. 28 at 9:35 PM

$LITS 🫠

0 · Reply

R3JS Jan. 27 at 8:43 PM

$LTCN $LTCN $LTCC $LITS ☢️☢️☢️🚀🚀🚀🚀🥇🥇🥇🥇🧸🔫🧸🔫☢️☢️☢️☢️🫡

0 · Reply

R3JS Jan. 27 at 8:41 PM

$LITS about to get a daily buy signal this is huge it’s time!!

1 · Reply

soccerplayer06 Jan. 27 at 4:41 PM

$LITS added a little more here. Discount city. $LTC.X

0 · Reply

Bestbee Jan. 26 at 5:59 PM

$LITS

0 · Reply

End00Game Jan. 24 at 1:53 AM

$LTC.X what's all the drama about ? $LITS $LTCN

0 · Reply

soccerplayer06 Jan. 23 at 2:24 PM

$LITS really wish they would announce something with litecoin being this low. Add more to rhe reserve, announce something! $LTC.X

2 · Reply

grtttttteasd Jan. 22 at 3:48 PM

$LITS Litecoins hashrate has exploded while price has remained the same. Historically for $BTC thks type of behavior leads to violent moves to the upside. $LTC is due for a massive repricing moment and lite strategy will benefit even more so bouncing off these lows

0 · Reply

Golibajje Jan. 21 at 5:39 PM

$LITS Cashless warrants from Sep 2025 financing and prefunded warrants from previous financing hurting the pricing! i wont believe price will recover until it goes to $1

1 · Reply

Market Cap	44.49M
Revenue (ttm)	0.00
Net Income (ttm)	-15.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	553,900
Avg Vol	597,978
Day's Range	N/A - N/A
Shares Out	36.77M
Stochastic %K	25%
Beta	0.27
Analysts	Hold
Price Target	N/A